{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:20:43Z","timestamp":1785388843769,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.clml.2019.01.002","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T06:04:53Z","timestamp":1548569093000},"page":"264-274.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Predictive Model for Infection Risk in Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Patients Treated With Azacitidine; Azacitidine Infection Risk Model: The Polish Adult Leukemia Group Study"],"prefix":"10.1016","volume":"19","author":[{"given":"Krzysztof","family":"M\u0105dry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Lis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Biecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"M\u0142ynarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagoda","family":"Rytel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"G\u00f3rka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7754-0564","authenticated-orcid":false,"given":"Piotr","family":"Kacprzyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Dutka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Rodzaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Bo\u0142kun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Krochmalczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"\u0141\u0105tka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Drozd-Soko\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Waszczuk-Gajda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Knopi\u0144ska-Pos\u0142uszny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kopi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Subocz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Masternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Guzicka-Kazimierczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"Machowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Bili\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Giebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Czerw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8572-0335","authenticated-orcid":false,"given":"Jadwiga","family":"Dwilewicz-Trojaczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2019.01.002_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(09)70003-8","article-title":"Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study","volume":"10","author":"Fenaux","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2019.01.002_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood-2015-01-621664","article-title":"International phase 3 study of azacitidine vs. conventional care regimens in older patients with newly diagnosed AML with >30% blasts","volume":"126","author":"Dombret","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.01.002_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00277-016-2649-3","article-title":"Causes of death in 2877 patients with myelodysplastic syndromes","volume":"95","author":"Nachtkamp","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2019.01.002_bib4","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/cncr.24894","article-title":"Azacitidine for the treatment of lower risk myelodysplastic syndromes: a retrospective study of 74 patients enrolled in an Italian named patient program","volume":"116","author":"Musto","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2019.01.002_bib5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00277-017-3001-2","article-title":"A\u00a0retrospective study evaluating the impact of infectious complications during azacitidine treatment","volume":"96","author":"Schuck","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2019.01.002_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00277-013-1698-0","volume":"92","author":"Neumann","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2019.01.002_bib7","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clml.2019.01.002_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clml.2013.09.014","article-title":"Patterns of infection in patients with myelodysplastic syndromes and acute myeloid leukemia receiving azacitidine as salvage therapy. Implications for primary antifungal prophylaxis","volume":"14","author":"Falantes","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2019.01.002_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ajh.23368","article-title":"Predicting infections in high-risk patients with myelodysplastic syndrome\/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study","volume":"88","author":"Merkel","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2019.01.002_bib10","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1080\/10428194.2017.1295141","article-title":"Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes","volume":"58","author":"Trubiano","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.01.002_bib11","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.clml.2019.01.002_bib12","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clml.2019.01.002_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/10428199609054829","article-title":"Granulocyte dysplasia and dysfunction, and CD11\/CD18 defects in myelodysplastic syndromes","volume":"23","author":"Mazzone","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.01.002_bib14","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1086\/317470","article-title":"Decline in antibiotic enzyme activity of neutrophils is a prognostic factor for infections in patients with myelodysplastic syndrome","volume":"31","author":"Ito","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clml.2019.01.002_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.leukres.2016.01.014","article-title":"Infections in patients with acute myeloid leukemia treated with low-intensity therapeutic regimens: risk factors and efficacy of antibiotic prophylaxis","volume":"42","author":"Bainschab","year":"2016","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2019.01.002_bib16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/tid.12130","article-title":"Epidemiology and risk factors for infections in myelodysplastic syndromes","volume":"15","author":"Sullivan","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.clml.2019.01.002_bib17","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00277-017-3091-x","article-title":"The impact of antimicrobial prophylaxis in morbidity and infections during azacitidine treatment","volume":"96","author":"Lorenzana","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2019.01.002_bib18","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/cncr.23773","article-title":"Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation","volume":"113","author":"Choi","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2019.01.002_bib19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/asheducation-2016.1.256","article-title":"Platelets in infectious disease","volume":"2016","author":"Middleton","year":"2016","journal-title":"Hematology"},{"key":"10.1016\/j.clml.2019.01.002_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.leukres.2010.07.006","article-title":"Decreased incidence of febrile episodes with antibiotic prophylaxis in the treatment of decitabine for myelodysplastic syndrome","volume":"35","author":"Lee","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2019.01.002_bib21","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.clml.2015.02.030","article-title":"Higher infection rate after 7- compared with 5-day cycle of azacitidine in patients with higher-risk myelodysplastic syndrome","volume":"15","author":"Ofran","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2019.01.002_bib22","first-page":"1151","article-title":"Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia","volume":"19","author":"Ahn","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clml.2019.01.002_bib23","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00277-014-2126-9","article-title":"Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group","volume":"93","author":"Pleyer","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2019.01.002_bib24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ajh.23654","article-title":"Azacitidine in untreated acute myeloid leukemia: a report on 149 patients","volume":"89","author":"Th\u00e9pot","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2019.01.002_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood-2010-06-289280","article-title":"Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine","volume":"117","author":"Itzykson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.01.002_bib26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/0885066616685300","article-title":"Predictive value of serum albumin level for the prognosis of severe sepsis without exogenous human albumin administration","volume":"33","author":"Yin","year":"2018","journal-title":"J\u00a0Intensive Care Med"},{"key":"10.1016\/j.clml.2019.01.002_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1200\/JOP.2012.000815","article-title":"Communicating safe outpatient management of fever and neutropenia","volume":"9","author":"Flowers","year":"2013","journal-title":"J\u00a0Oncol Pract"},{"issue":"suppl 5","key":"10.1016\/j.clml.2019.01.002_bib28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/annonc\/mdq196","article-title":"Management of febrile neutropenia: ESMO clinical practice guidelines","volume":"21","author":"de Naurois","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2019.01.002_bib29","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265018315106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265018315106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:31:50Z","timestamp":1761870710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265018315106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2152265018315106"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2019.01.002","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive Model for Infection Risk in Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Patients Treated With Azacitidine; Azacitidine Infection Risk Model: The Polish Adult Leukemia Group Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2019.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}